Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,506,835 | 1,365,980 | 1,215,529 | 1,052,898 | 1,178,698 |
| Cost of Goods | 121,175 | 99,001 | 78,766 | 73,188 | 88,485 |
| Gross Profit | 1,385,660 | 1,266,979 | 1,136,763 | 979,710 | 1,090,213 |
| Operating Expenses | 1,049,976 | 823,462 | 607,215 | 774,730 | 789,185 |
| Operating Income | 335,859 | 443,518 | 530,314 | 205,168 | 301,513 |
| Interest Expense | 582 | 592 | 594 | 660 | 419 |
| Other Income | 54,664 | 39,382 | 28,292 | 29,682 | 12,630 |
| Pre-tax Income | 389,941 | 482,308 | 558,012 | 234,190 | 313,724 |
| Income Tax | 90,662 | 58,139 | 153,013 | 75,987 | 112,512 |
| Net Income Continuous | 299,279 | 424,169 | 404,999 | 158,203 | 201,212 |
| Net Income | $299,279 | $424,169 | $404,999 | $158,203 | $201,212 |
| EPS Basic Total Ops | 1.51 | 2.17 | 2.09 | 0.82 | 0.89 |
| EPS Basic Continuous Ops | 1.52 | 2.17 | 2.09 | 0.82 | 0.89 |
| EPS Diluted Total Ops | 1.46 | 2.11 | 2.04 | 0.80 | 0.90 |
| EPS Diluted Continuous Ops | 1.47 | 2.11 | 2.04 | 0.80 | 0.90 |
| EPS Diluted Before Non-Recurring Items | 1.56 | 2.03 | 1.31 | 0.89 | 1.09 |
| EBITDA(a) | $359,841 | $467,541 | $553,233 | $227,530 | $324,246 |